|
STAT2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.63480348650091E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.79579999981527E-07 |
| Normal-vs-Stage2 |
1.098110E-03 |
| Normal-vs-Stage3 |
6.448900E-04 |
| Normal-vs-Stage4 |
2.418000E-01 |
| Stage1-vs-Stage2 |
6.081600E-02 |
| Stage1-vs-Stage3 |
8.621600E-01 |
| Stage1-vs-Stage4 |
7.087000E-01 |
| Stage2-vs-Stage3 |
1.783240E-01 |
| Stage2-vs-Stage4 |
2.528400E-01 |
| Stage3-vs-Stage4 |
6.778600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.42380004955578E-10 |
| Normal-vs-AfricanAmerican |
2.04159999999121E-05 |
| Normal-vs-Asian |
4.095700E-02 |
| Caucasian-vs-AfricanAmerican |
8.830400E-01 |
| Caucasian-vs-Asian |
3.265600E-01 |
| AfricanAmerican-vs-Asian |
3.476400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.03039848559683E-11 |
| Normal-vs-Female |
3.6385000001804E-07 |
| Male-vs-Female |
9.976000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.438700E-04 |
| Normal-vs-Extreme_Weight |
6.71280000030805E-07 |
| Normal-vs-Obese |
9.40419999984066E-07 |
| Normal-vs-Extreme_Obese |
3.264400E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.020000E-01 |
| Normal_Weight-vs-Obese |
2.223800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.746400E-01 |
| Extreme_Weight-vs-Obese |
4.599600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.492600E-01 |
| Obese-vs-Extreme_Obese |
1.037620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.82850001385316E-09 |
| Normal-vs-Age(41-60Yrs) |
1.21159970944973E-10 |
| Normal-vs-Age(61-80Yrs) |
5.40000000270879E-08 |
| Normal-vs-Age(81-100Yrs) |
1.311160E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.012800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.400100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.718300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.902600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.890990E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.578400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.65978342181461E-13 |
| Normal-VS-Type2 PRCC |
7.335600E-02 |
| Normal-VS-KIRP CIMP |
2.981600E-02 |
| Normal-VS-Unclassified PRCC |
2.62470000000903E-06 |
| Type1 PRCC-VS-Type2 PRCC |
4.85800000005199E-07 |
| Type1 PRCC-VS-KIRP CIMP |
5.002000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.475800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.299050E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.570800E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
2.691200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.22650000000813E-05 |
| Normal-vs-N1 |
4.368900E-04 |
| Normal-vs-N2 |
5.203500E-02 |
| N0-vs-N1 |
1.958790E-01 |
| N0-vs-N2 |
7.582200E-01 |
| N1-vs-N2 |
4.229200E-01 |
|
|
